Update on endoscopic surgery in Japan: Results of the 16th National Survey of endoscopic surgery by the Japan Society for Endoscopic Surgery
Hidefumi Shiroshita,Masafumi Inomata,Shuji Takiguchi,Shigeo Akira,Hiroomi Kanayama,Shigeki Yamaguchi,Susumu Eguchi,Norihito Wada,Yukinori Kurokawa,Tomonori Akagi,Yosuke Seki,Satoshi Ieiri,Masayuki Iwazaki,Yukio Sato,Kaoru Kitamura,Minoru Tabata,Akira Miyajima,Fuminori Taniguchi,Hiroshi Takahashi,Tetsuji Uemura,Shunsuke Tsukamoto,Aya Kanehira,Kazuma Okamoto,Makoto Hashizume,Sumio Matsumoto,Seigo Kitano,Masahiko Watanabe,Yoshiharu Sakai
DOI: https://doi.org/10.1111/ases.13285
Abstract:This article reports the results of the 16th National Survey conducted by the Japan Society for Endoscopic Surgery (JSES) for 2020 and 2021. Laparoscopic cholecystectomy was first introduced to Japan in 1990 and has rapidly become popular because of its minimally invasive nature. Since then, the number of objective organs and indications for laparoscopic surgery have gradually expanded. In 2021, 290 787 patients underwent endoscopic surgery in all surgical domains. Of these, 124 614, 110 757, 23 156, 21 771, 6543, 2614, 535, 465, 247, and 58 underwent abdominal, obstetric and gynecologic, thoracic, urological, pediatric, orthopedic, bariatric, mammary and thyroid gland, cardiovascular, and plastic surgery, respectively. Owing to the impact of the coronavirus disease 2019 (COVID-19) infection spread, the incidence of many surgeries decreased in 2020, and levels are only now gradually recovering. However, despite the impact of COVID-19, robot-assisted surgeries were increasingly applied. The rate of complications did not change significantly, indicating that the procedure was performed safely, even with the spread of COVID-19.